Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
BMJ Open|June 20, 2023
Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional studyRui Huang, Jian-Gao Fan, Jun-Ping Shi, et al.
European Journal of Medical Research|January 10, 2026
Triglyceride-glucose body mass index and risk of incident venous thromboembolism: a prospective cohort study from the UK BiobankShen-Shen Huang, Shuang-Ping Li, Chai-Yi Xie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 24, 2023
Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in ChinaRui Huang, Jian-Gao Fan, Jun-Ping Shi, et al.
World Journal of Gastroenterology|November 8, 2003
Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parametersLun-Gen Lu, Min-De Zeng, Mo-Bin Wan, et al.
Acta Pharmacologica Sinica|August 5, 2025
Betaine-homocysteine methyltransferase protects against acetaminophen-induced acute liver failure via BACH1-SCD1-oleic acid axisYu-Ting Zhang, Xiao-Ming Yang, Quan-Shan Jin, et al.
Journal of Digestive Diseases|February 2, 2018
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trialYong Feng Wang, Jie Ting Tang, Tao Han, et al.
World Journal of Gastroenterology|December 12, 2003
Relationship between clinical and pathologic findings in patients with chronic liver diseasesLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
Health and Quality of Life Outcomes|May 8, 2021
Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter surveyRui Huang, Jian-Gao Fan, Jun-Ping Shi, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 27, 2004
[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial]Lun-gen Lu, Min-de Zeng, Yi-min Mao, et al.
World Journal of Gastroenterology|October 16, 2004
Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical studyYi-Min Mao, Min-De Zeng, Lun-Gen Lu, et al.
Pageof 5